Lataa...
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival
BACKGROUND. No laboratory test can predict the risk of nonrelapse mortality (NRM) or severe graft-versus-host disease (GVHD) after hematopoietic cellular transplantation (HCT) prior to the onset of GVHD symptoms. METHODS. Patient blood samples on day 7 after HCT were obtained from a multicenter set...
Tallennettuna:
| Julkaisussa: | JCI Insight |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5291735/ https://ncbi.nlm.nih.gov/pubmed/28194439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.89798 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|